Page - (000412) - in Biomedical Chemistry: Current Trends and Developments

90-99. Wang, R., Billone, P. S., Mullett, W. M. (2013). Nanomedicine in action: An overview of cancer nanomedicine on the market and in clinical trials. Journal of Nanomaterials, 2013, 629681. Wang, Y. X., Hussain, S. M., Krestin, G. P. (2001). Superparamagnetic iron oxide contrast agents: Physicochemical characteristics and applications in mr imaging. European Radiology, 11(11), 2319-2331. Weber, C., Drogoz, A., David, L., et al. (2010). Polysaccharide-based vaccine delivery systems: Macromolecular assembly, interactions with antigen presenting cells, and in vivo immunomonitoring. Journal of Biomedical Materials Research Part A, 93(4), 1322-1334. Weiner, L. M., Adams, G. P. (2000). New approaches to antibody therapy. Oncogene, 19(53), 6144-6151. Whitehead, K. A., Langer, R., Anderson, D. G. (2009). Knocking down barriers: Advances in sirna delivery. Nature Reviews Drug Discov, 8(2), 129-138. WHO. (2014). Cancer. World Health Organization Retrieved 27th October, 2014, from http://www.who.int/topics/cancer/en/. Wong, C., Stylianopoulos, T., Cui, J., et al. (2011). Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proceedings of the National Academy of Sciences, 108(6), 2426-2431. Wu, K. Y., Wu, M., Fu, M. L., et al. (2006). A novel chitosan cpg nanoparticle regulates cellular and humoral immunity of mice. Biomedical and Environmental Sciences, 19(2), 87-95. Xia, T., Kovochich, M., Liong, M., et al. (2009). Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of sirna and DNA constructs. ACS Nano, 3(10), 3273-3286. Xiang, S. D., Wilson, K., Day, S., et al. (2013). Methods of effective conjugation of antigens to nanoparticles as non-inflammatory vaccine carriers. Methods, 60(3), 232-241. Xie, J., Lee, S., Chen, X. (2010). Nanoparticle-based theranostic agents. Advanced Drug Delivery Reviews, 62(11), 1064-1079. Xie, R., Dong, L., Huang, R., et al. (2014). Targeted imaging and proteomic analysis of tumor- associated glycans in living animals. Angewandte Chemie International Edition, 53(51), 14082-14086. Yanes, R. E., Tamanoi, F. (2012). Development of mesoporous silica nanomaterials as a vehicle for anticancer drug delivery. Therapeutic Delivery, 3(3), 389-404. Yang, K. N., Zhang, C. Q., Wang, W., et al. (2014). Ph-responsive mesoporous silica nanoparticles employed in controlled drug delivery systems for cancer treatment. Cancer Biology & Medicine, 11(1), 34-43. Yang, S., Li, N., Chen, D., et al. (2013). Visible-light degradable polymer coated hollow mesoporous silica nanoparticles for controlled drug release and cell imaging. Journal of Materials Chemistry B, 1(36), 4628-4636. Yoshida, T., Mei, H., Dorner, T., et al. (2010). Memory b and memory plasma cells. Immunology Reviews, 237(1), 117-139. Yotsumoto, S., Aramaki, Y., Kakiuchi, T., et al. (2004). Induction of antigen-dependent interleukin-12 production by negatively charged liposomes encapsulating antigens. Vaccine, 22(25-26), 3503-3509.